The present invention discloses novel (R) and (S) Styrene Oxide based asymmetric synthesis for preparation of Phenyramidol enantiomers and to their pharmaceutically acceptable salts with high chiral purity. This invention further discloses clinical evaluation of (R) and (S) enantiomers of Phenyramidol, their salts and compositions thereof for enhanced/newer therapeutic benefits.